Back
First Trust RBA Amer Indl RenaisTM ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
68
AIRR
First Trust RBA Amer Indl RenaisTM ETF
Last Price:
68.96
Seasonality Move:
3.92%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Buy
68
First Trust RBA Amer Indl RenaisTM ETF (AIRR)
is a Buy
Is First Trust RBA Amer Indl RenaisTM ETF a Buy, Sell or Hold?
- The current First Trust RBA Amer Indl RenaisTM ETF [AIRR] share price is $68.96. The Score for AIRR is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- AIRR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AIRR Stock Price Chart
What is First Trust RBA Amer Indl RenaisTM ETF's stock price today?
-
The First Trust RBA Amer Indl RenaisTM ETF share price today is $68.96
The current trend is moderately bearish and AIRR is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
AIRR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.16 | Sell |
| Chaikin Money Flow: | 38374 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.04 - 71.96) | Sell |
| Bollinger Bands (100): | (61.5 - 69.68) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.7 | Sell |
| Relative Strength Index (14 RSI): | 46.74 | Sell |
| Chaikin Money Flow: | 84619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.82 - 42.02) | Sell |
| Bollinger Bands (100): | (40.86 - 48.8) | Sell |
AIRR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.43 | Sell |
| 20-day SMA: | 70.18 | Sell |
| 50-day SMA: | 68.27 | Buy |
| 200-day SMA: | 59.04 | Buy |
| 8-day EMA: | 69.37 | Sell |
| 20-day EMA: | 69.66 | Sell |
| 50-day EMA: | 68.44 | Buy |
| 200-day EMA: | 61.14 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.53 | Buy |
| 20-day SMA: | 40.36 | Sell |
| 50-day SMA: | 41.57 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 39.71 | Buy |
| 20-day EMA: | 40.38 | Sell |
| 50-day EMA: | 41.84 | Sell |
| 200-day EMA: | 43.38 | Sell |
First Trust RBA Amer Indl RenaisTM ETF Earnings Growth & AIRR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
First Trust RBA Amer Indl RenaisTM ETF Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||